2025.02.26
Notice of Board of Directors Appointments
February 26, 2025
J-Pharma Co., Ltd.
J-Pharma Co. Ltd. (Headquarters: Yokohama City, Kanagawa Prefecture; CEO: Masuhiro Yoshitake) announces that Mr. Takuma Tsuzuku was elected as an outside director at the extraordinary shareholders meeting held on February 25, 2025. In addition, the Company would like to report the following executive structure.
| Title | Name | |
| Representative Director and President & CEO |
Masuhiro Yoshitake | Continuation |
| Director and Chief Financial Officer (CFO) |
Yutaka Fujimoto | Continuation |
| External Director | Sadashi Suzuki | Continuation |
| External Director | Shinichiro Komoto | Continuation |
| External Director | Kazunobu Nishimura | Continuation |
| External Director | Reiri Miura | Continuation |
| External Director | Takuma Tsuzuku | New |
| External Director, Audit and Supervisory Committee Member | Toshiyuki Mori | Continuation |
| External Director, Audit and Supervisory Committee Member | Teruhisa Tajima | Continuation |
| External Director, Audit and Supervisory Committee Member | Kosaku Kawaguchi | Continuation |
Mr. Takuma Tsuzuku has worked in basic research, product development activities, and research planning as a researcher for a major pharmaceutical company, and later as a venture capitalist, investing in global biotech companies. Currently, he is engaged in investment activities in the biotech area with a focus on drug discovery at JIC Venture Growth Investments Co., Ltd.
With the appointment of Mr. Takuma Tsuzuku as an outside director, the Company will strengthen its corporate governance, accelerate its global expansion, and enhance its corporate value.
Inquiries:
J-Pharma Co., Ltd.
Administration Department Public Relations
https://www.j-pharma.com/en/contact
